Tevogen BioEquity Warrant Exp 14 February 2029 logo

Tevogen BioEquity Warrant Exp 14 February 2029 Share Price Today

(NASDAQ: TVGNW)

Tevogen BioEquity Warrant Exp 14 February 2029 share price is $0.05 & ₹4.27 as on 18 Apr 2025, 2.30 'hrs' IST

$0.05

Market is closed - opens 7 PM, 21 Apr 2025

View live Tevogen BioEquity Warrant Exp 14 February 2029 share price in Dollar and Rupees. Guide to invest in Tevogen BioEquity Warrant Exp 14 February 2029 stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Tevogen BioEquity Warrant Exp 14 February 2029, along with analyst recommendations, forecasts, and comprehensive financials.

Tevogen BioEquity Warrant Exp 14 February 2029 share price movements

  • Today's Low: $0.05
    Today's High: $0.05

    Day's Volatility :3.5%

  • 52 Weeks Low: $0.01
    52 Weeks High: $0.15

    52 Weeks Volatility :93.4%

Tevogen BioEquity Warrant Exp 14 February 2029 (TVGNW) Returns

PeriodTevogen Bio Holdings Equity Warrant Exp 14 February 2029Index (Russel 2000)
3 Months
-37.34%
0.0%
6 Months
-23.29%
0.0%
1 Year
-19.58%
0.0%
3 Years
-49.21%
-12.9%

Tevogen BioEquity Warrant Exp 14 February 2029 (TVGNW) Key Statistics

in dollars & INR

Previous Close
$0.0459
Open
$0.04825
Today's High
$0.05
Today's Low
$0.04825
Today's Volume
$891.0
52 Week High
$0.1499
52 Week Low
$0.0099
Revenue TTM
$0.0
EBITDA
$-53.4M
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

How to invest in Tevogen BioEquity Warrant Exp 14 February 2029 Stock (TVGNW) from India?

It is very easy for Indian residents to invest directly in Tevogen BioEquity Warrant Exp 14 February 2029 from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Tevogen BioEquity Warrant Exp 14 February 2029 stock in both Indian Rupees (INR) and US Dollars (USD). Search for Tevogen BioEquity Warrant Exp 14 February 2029 or TVGNW on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Tevogen BioEquity Warrant Exp 14 February 2029 or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Tevogen BioEquity Warrant Exp 14 February 2029 shares which would translate to 17.093 fractional shares of Tevogen BioEquity Warrant Exp 14 February 2029 as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Tevogen BioEquity Warrant Exp 14 February 2029, in just a few clicks!

Returns in Tevogen BioEquity Warrant Exp 14 February 2029 (TVGNW) for Indian investors in Rupees

The Tevogen BioEquity Warrant Exp 14 February 2029 stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Tevogen BioEquity Warrant Exp 14 February 2029 investment value today

Current value as on today

₹85,674

Returns

₹14,326

(-14.33%)

Returns from Tevogen BioEquity Warrant Exp 14 February 2029 Stock

₹16,667 (-16.67%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Tevogen BioEquity Warrant Exp 14 February 2029 (TVGNW)

-7%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Tevogen BioEquity Warrant Exp 14 February 2029 Stock from India on INDmoney has decreased by -7% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Tevogen BioEquity Warrant Exp 14 February 2029

Rating
Trend

Insights on Tevogen BioEquity Warrant Exp 14 February 2029 Stock (Ticker Symbol: TVGNW)

  • Price Movement

    In the last 7 days, TVGNW stock has moved up by 6.5%
  • TVGNW vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 99.6%

Tevogen BioEquity Warrant Exp 14 February 2029 Technicals Summary

Sell

Neutral

Buy

Tevogen BioEquity Warrant Exp 14 February 2029 is currently in a neutral trading position according to technical analysis indicators.

Tevogen BioEquity Warrant Exp 14 February 2029 (TVGNW) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Tevogen Bio Holdings Equity Warrant Exp 14 February 2029 logo
-19.19%
-23.29%
-19.58%
-49.21%
-49.21%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Tevogen BioEquity Warrant Exp 14 February 2029

Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients. It is also developing TVGN 920 for treating cervical cancer; TVGN 960 for treating oropharyngeal cancer; TVGN 601 for treating MS; and TVGN 930 for treating EBV-associated lymphomas. The company was founded in 2020 and is headquartered in Warren, New Jersey.
Organization
Tevogen BioEquity Warrant Exp 14 February 2029
Employees
18
CEO
Dr. Ryan H. Saadi M.D., M.P.H, M.P.H.
Industry
Miscellaneous

Management People of Tevogen BioEquity Warrant Exp 14 February 2029

NameTitle
Dr. Ryan H. Saadi M.D., M.P.H, M.P.H.
Co-Founder, CEO & Chairperson
Mr. Kirti Desai CPA
Chief Financial Officer
Dr. Neal Flomenberg M.D.
Chief Scientific Officer and Global R&D Lead
Mr. Stephen Chen M.B.A.
Chief Technical Officer
Mr. Mittul Mehta
Chief Information Officer & Head of Tevogen.ai
Mr. Tapan V. Shah
Head of Investor Relations & Corporate Development
Mr. Sadiq Khan M.B.A.
Chief Commercial Officer
Mr. David E. Banko CPA
Global Head of Government Affairs & Patient Access

Important FAQs about investing in TVGNW Stock from India :

What is Tevogen BioEquity Warrant Exp 14 February 2029 share price today?

Tevogen BioEquity Warrant Exp 14 February 2029 share price today stands at $0.05, Open: $0.05 ; Previous Close: $0.05 ; High: $0.05 ; Low: $0.05 ; 52 Week High: $0.15 ; 52 Week Low: $0.01.

The stock opens at $0.05, after a previous close of $0.05. The stock reached a daily high of $0.05 and a low of $0.05, with a 52-week high of $0.15 and a 52-week low of $0.01.

Can Indians buy Tevogen BioEquity Warrant Exp 14 February 2029 shares?

Yes, Indians can invest in the Tevogen BioEquity Warrant Exp 14 February 2029 (TVGNW) from India.

With INDmoney, you can buy Tevogen BioEquity Warrant Exp 14 February 2029 at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Tevogen BioEquity Warrant Exp 14 February 2029 at zero transaction cost.

How can I buy Tevogen BioEquity Warrant Exp 14 February 2029 shares from India?

It is very easy to buy Tevogen BioEquity Warrant Exp 14 February 2029 from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Tevogen BioEquity Warrant Exp 14 February 2029 (TVGNW) be purchased?

Yes, you can buy fractional shares of Tevogen BioEquity Warrant Exp 14 February 2029 with INDmoney app.

What are the documents required to start investing in Tevogen BioEquity Warrant Exp 14 February 2029 stocks?

To start investing in Tevogen BioEquity Warrant Exp 14 February 2029, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Tevogen BioEquity Warrant Exp 14 February 2029 Stock (TVGNW)?

Today’s highest price of Tevogen BioEquity Warrant Exp 14 February 2029 (TVGNW) is $0.05.

Today’s lowest price of Tevogen BioEquity Warrant Exp 14 February 2029 (TVGNW) is $0.05.

What is today's market capitalisation of Tevogen BioEquity Warrant Exp 14 February 2029?

Today's market capitalisation of Tevogen BioEquity Warrant Exp 14 February 2029 TVGNW is 84.9M

What is the 52 Week High and Low Range of Tevogen BioEquity Warrant Exp 14 February 2029 Stock (TVGNW)?

  • 52 Week High

    $0.15

  • 52 Week Low

    $0.01

What are the historical returns of Tevogen BioEquity Warrant Exp 14 February 2029 (TVGNW)?

  • 1 Month Returns

    -19.19%

  • 3 Months Returns

    -23.29%

  • 1 Year Returns

    -19.58%

  • 5 Years Returns

    -49.21%

Who is the Chief Executive Officer (CEO) of Tevogen BioEquity Warrant Exp 14 February 2029 ?

Dr. Ryan H. Saadi M.D., M.P.H, M.P.H. is the current Chief Executive Officer (CEO) of Tevogen BioEquity Warrant Exp 14 February 2029.